Jci_page_head_homepage_01 Jci_page_head_homepage_02
Haiyan Xu, Glenn T. Barnes, Qing Yang, Guo Tan, Daseng Yang, Chieh J. Chou, Jason Sole, Andrew Nichols, Jeffrey S. Ross, Louis A. Tartaglia, Hong Chen
Published in Volume 112, Issue 12
J Clin Invest. 2003; 112(12):1821–1830 doi:10.1172/JCI19451
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6

The expression of ADAM8, MIP-1α, MCP-1, MAC-1, F4/80, and CD68 in ob/ob WAT treated with rosiglitazone. Twelve-week-old ob/ob mice were treated with either 15 mg/kg rosiglitazone (Rosi) or vehicle (sterile water; Veh) for 28 consecutive days (n = 10 in each group). For comparison, the expression level in rosiglitazone-treated ob/ob mice was arbitrarily set at 1; error bars represent ± SE; *P < 0.05. y axes show arbitrary units representing relative expression levels of mRNAs.